D292-0292 Screening compound: 1-(1,3-benzothiazol-2-yl)-4-(3-bromophenyl)-3-methyl-1H,4H,5H,6H,7H-pyrazolo[3,4-b]pyridin-6-one

D292-0292 Screening compound: 1-(1,3-benzothiazol-2-yl)-4-(3-bromophenyl)-3-methyl-1H,4H,5H,6H,7H-pyrazolo[3,4-b]pyridin-6-one
D292-0292 Screening compound: 1-(1,3-benzothiazol-2-yl)-4-(3-bromophenyl)-3-methyl-1H,4H,5H,6H,7H-pyrazolo[3,4-b]pyridin-6-one alternative view

Chemical Structure Depiction of ChemDiv screening compound D292-0292
1-(1,3-benzothiazol-2-yl)-4-(3-bromophenyl)-3-methyl-1H,4H,5H,6H,7H-pyrazolo[3,4-b]pyridin-6-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D292-0292

Molecular Formula

C20H15BrN4OS (C20 H15 BrN4 OS)

Compound Name

1-(1,3-benzothiazol-2-yl)-4-(3-bromophenyl)-3-methyl-1H,4H,5H,6H,7H-pyrazolo[3,4-b]pyridin-6-one

IUPAC name

1-(13-benzothiazol-2-yl)-4-(3-bromophenyl)-3-methyl-1H4H5H6H7H-pyrazolo[34-b]pyridin-6-one

SMILES

Cc(c(C(C1)c2cccc(Br)c2)c2NC1=O)nn2-c1nc(cccc2)c2s1

InChI

InChI=1S/C20H15BrN4OS/c1-11-18-14(12-5-4-6-13(21)9-12)10-17(26)23-19(18)25(24-11)20-22-15-7-2-3-8-16(15)27-20/h2-9,14H,10H2,1H3,(H,23,26)/t14-/m1/s1

InChI Key

VDYMYAAPHMPECA-CQSZACIVSA-N

MDL Number (MFCD)

MFCD14816930

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

439.34

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

2.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.904

Distribution Coefficient, logD

4.902

Water Solubility, LogSw

-4.68

Polar Surface Area

48.627

Acid Dissociation Constant (pKa)

11.21

Base Dissociation Constant (pKb)

5.04

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

15.00

D292-0292 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with D292-0292 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D292-0292?
Check Price and Availability of D292-0292, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D292-0292 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D292-0292
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D292-0292
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D292-0292 available by request